How It Works
Through our exclusive license to patented EEG technology developed at UPenn Medicine, GlassView captures clinical-grade brain data directly from audiences engaging with real ad content. We measure engagement, emotional response, and memory encoding in real time -- not after the fact, not through recall surveys, not through modeled proxies.
That signal feeds two things simultaneously: smarter creative decisions before a campaign launches, and smarter optimization decisions while it runs.
The result is a behavioral validation dataset unlike anything else in advertising. Built across real campaigns. Validated at real scale. Impossible to replicate through AI or modeling, because it comes directly from the brain.
Why This Changes the Math on Media
Every other platform measures what audiences did. GlassView measures what audiences felt -- and uses that to predict what they will do.
That distinction compounds over time. Every campaign adds to a validation history that makes the next campaign more precise. The brands that work with GlassView aren't just buying media. They are building a proprietary understanding of what moves their specific audience, grounded in the only data source that cannot be reverse-engineered.
The Moat
GlassView holds an exclusive license to use this EEG technology in media buying and delivery -- the application that matters most to the brands we serve. No other advertising platform has access to it.
The hardware produces brain data. The campaigns validate it at scale. The dataset compounds with every impression. That is a moat that cannot be bought, modeled, or built from scratch by a competitor.
GlassView also holds an equity stake in Cogwear, the neuroscience company behind the technology, which operates as a separate entity in its own markets.
GlassView reaches over 2.7 billion unique viewers every month across every connected screen. If you want to stop guessing what moves your audience and start measuring it, we want to work with you.

